|
|
|
|
|
||||||||||||
|
|
|
|
|
|
|
|
Valuation Estimation |
EPS (Current/Estimated)
4.18/6.08
|
Enterprise Value
47.93B
|
Balance Sheet |
Book Value Per Share
21.12
|
Cash Flow |
Cash Flow Yield
0.04
|
Income Statement |
Total Revenue
6.83B
|
Operating Revenue Per Share
23.87
|
Industry Comparison
|
||||||||||||||||||||||||||||||||||||||||||||||||
|
Quotes are at least 15-min delayed:2024/05/20 16:19 EDT
Industry overview quotes are at least 15 minutes delayed
Business Description
|
|||
Originally spun out of Hewlett-Packard in 1999, Agilent has evolved into a leading life sciences and diagnostics firm. Today, Agilent's measurement technologies serve a broad base of customers with its three operating segments: life science and applied tools, cross lab (consisting of consumables and services related to life science and applied tools), and diagnostics and genomics. Over half of its sales are generated from the biopharmaceutical, chemical, and advanced materials end markets, but it also supports clinical lab, environmental, forensics, food, academic, and government-related organizations. The company is geographically diverse, with operations in the U.S. and China representing the largest country concentrations. |